Table 1. Anti–β1 integrin mAbs.
Clone | Species | Epitope | Conformational specificity | Function | Classification | References |
---|---|---|---|---|---|---|
K20 | Mouse | EGF-like repeats | Pan | - | Total | Amiot et al. (1986); Takada and Puzon (1993) |
9EG7 | Rat | EGF-like repeats | Extended; LIBSa | Activating | Active | Lenter et al. (1993); Bazzoni et al. (1995); Su et al. (2016) |
12G10 | Mouse | βA domain | Open headpiece; LIBS | Activating | Active | Mould et al. (1995, 1996,Su et al. (2016) |
Huts-4 | Mouse | Hybrid domain | Open headpiece; LIBS | Activating | Active | Luque et al. (1996); Su et al. (2016) |
mAb13 | Rat | βA domain | Closed headpiece; LABS | Inhibitory | Inactive | Akiyama et al. (1989); Mould et al. (1996); Su et al. (2016) |
AIIB2 | Rat | βA domain | LABS | Inhibitory | Inactive | Fig. S1; Werb et al. (1989); Takada and Puzon (1993); Park et al. (2008) |
We defined β1 integrin subpopulations labeled by different mAbs as total, active, and inactive as described in Materials and methods. All mAbs defined as active in this study label the same subpopulation as seen by a maximal colocalization (Fig. 3).
Ligand-induced binding site.